Drug Shortage Report for ADACEL

Last updated on 2020-09-30 History
Report ID 121077
Drug Identification Number 02240255
Brand name ADACEL
Common or Proper name Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed
Company Name SANOFI PASTEUR LIMITED
Market Status MARKETED
Active Ingredient(s) FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID PERTACTIN DIPHTHERIA TOXOID TETANUS TOXOID FIMBRIAE TYPES 2 AND 3
Strength(s) 5MCG 2.5MCG 3MCG 2LF 5LF 5MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 x 0.5 mL vial and 5 x 0.5 mL vials
ATC code J07AJ
ATC description BACTERIAL VACCINES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2020-07-24
Actual start date 2020-07-24
Estimated end date 2021-03-31
Actual end date 2020-09-29
Shortage status Resolved
Updated date 2020-09-30
Company comments Reason for Shortage: Due to delays in manufacturing and shipment of product for Canada | Allocation plan in place to meet public market demand; product not available for private market
Health Canada comments
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 416-667-2611 or 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2779 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-09-30 French Compare
v6 2020-09-30 English Compare
v5 2020-07-25 English Compare
v4 2020-07-24 French Compare
v3 2020-07-24 French Compare
v2 2020-07-24 English Compare
v1 2020-07-24 English Compare